show episodes
 
The Life Sciences D’n’A podcast is hosted by Dr. Amar Drawid, an industry veteran and AI expert who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
  continue reading
 
Artwork
 
Psychedelics Today is the planetary leader in psychedelic education, media, and advocacy. Covering up-to-the-minute developments and diving deep into crucial topics bridging the scientific, academic, philosophical, societal, and cultural, Psychedelics Today is leading the discussion in this rapidly evolving ecosystem.
  continue reading
 
Artwork

1
Go Fund This!

Southgate Media Group

Unsubscribe
Unsubscribe
Monthly
 
Go Fund This! finds current, running crowdfunding projects and sits down with their project managers to discuss their projects more in-depth. We focus on Kickstarters, Indie GoGos, Patreons, and other projects needing funding and we interview the people involved to help them get the word out. Games, comics, movies, books, music, and more! We cover it all.
  continue reading
 
Let’s Talk PR & More, hosted by Sherry Goldman of Goldman Communications Group, features an in-depth conversation with an industry leader sharing their insights and expertise on an aspect of public relations and/or the disciplines and issues that impact public relations. Topics range from the PR industry, best practices, profiles of industry leaders, related industries including the media, marketing, and advertising, and issues that impact communications and PR, such as AI. Let’s Talk PR & M ...
  continue reading
 
Loading …
show series
 
Sherry Goldman's guest is Jerry Barmash, a New York area broadcaster and reporter and author of the new book Here Now The News. Sherry and Jerry talk about Jerry's new book Here Now The News, which focuses on the stories of local TV news anchors and reporters, discussing how broadcast talent both reflects and also shapes the news covered.…
  continue reading
 
Jungian psychology takes a fascinating look at the relationship between the conscious and unconscious parts of our minds. How is this framework brought more to the forefront through psychedelics and an understanding of our many parts? In this episode of Vital Psychedelic Conversations, Johanna interviews Jung experts and Vital instructors: Maria Pa…
  continue reading
 
The body has a natural mechanism for breaking down and clearing proteins. Arvinas is among a group of companies that’s seeking to harness this mechanism for therapeutic purposes. It has platform technology that enables the development of targeted protein degraders to breakdown disease-causing proteins. Among the benefits of this approach is that it…
  continue reading
 
As many mushroom enthusiasts will attest: the more you learn about the fungal kingdom, the more you see how important mushrooms are to every ecosystem they’re a part of – and how life-changing a relationship with them can be. In this episode, Joe interviews Jasper Degenaars: mycologist, educator, and the Hyphae Headmaster at Fungi Academy, offering…
  continue reading
 
Rob interviews artist, Zack Howe, about the Kickstarter for the new card game, "Havoc: Gen Zero". Check out the trailer! https://www.youtube.com/watch?v=LEjSMySlK6k Instagram https://www.instagram.com/havoctcg/ Facebook https://www.facebook.com/havoctcg/ Discord https://discord.gg/zeJvEgHT X https://x.com/HAVOCtcg Website enterhavoc.com +++++++++++…
  continue reading
 
Sherry Goldman's guest is Ray Hennessey, CEO and executive partner of Vocatus and author of the book Beyond Sorry: How to Own Up, Make Good and Move Forward After a Crisis. Sherry and Ray discuss crisis communications and best practices for corporate apologies.By Sherry Goldman
  continue reading
 
Psychedelics in palliative care has become an exciting new framework for people looking to ease anxiety and embrace spirituality, but the concept is not as simple as just providing a substance. In this episode, Joe interviews Livi Joy: Director of Health and Safety, Existential Palliative Ministry Lead Facilitator, and more at Sacred Garden Communi…
  continue reading
 
The traditional approach to treating autoimmune disease has relied on ways to suppress the immune system. COUR Pharmaceuticals is developing first-in-class therapies that instead seek to reprogram the immune system to create antigen-specific tolerance. We spoke to COUR CEO John Puisis and COUR Vice President of Research Adam Elhofy, about how the c…
  continue reading
 
In this episode, Joe interviews Erica Rex, MA: award-winning journalist, past guest, thought leader on psychedelic medicine, and participant in one of the first clinical trials using psilocybin to treat cancer-related depression. She tells the story of her recent harrowing experience, brought on by 6 times the amount of Syrian rue that was recommen…
  continue reading
 
In this episode of Vital Psychedelic Conversations, Johanna interviews Monica Nieto: Vital graduate, psychedelic facilitator and integration coach, and founder of Holistic TherapeutiX, a retreat center offering cannabis and breathwork retreats; and Jordana Ma: past Vital instructor and psychological counselor who runs retreats in Peru following the…
  continue reading
 
The next blockbuster drug may already be in production by bacteria within your body. Bacteria produce unique chemical compounds that are bioactive and may have great therapeutic potential, but this chemical space has largely not been mined. Empress Therapeutics, a Flagship Pioneering company, is searching for such molecules by exploring the genes o…
  continue reading
 
In this episode, Joe interviews Jon Reiss: critically acclaimed filmmaker, author, and host of the Plantscendence podcast, which tells people’s psychedelic stories and is beginning its second season soon. He talks about his early days of directing Nine Inch Nails and Type O Negative videos, and how Plantscendence was born after he realized that the…
  continue reading
 
Sherry Goldman's guest is Jerry Pionk, owner and principal of Xcelsior Communications. Sherry and Jerry discuss AI and how government entities are using AI in PR and communications initiatives. Jerry shares his experiences using AI and handling communications in key government roles, including for the King County Department of Local Services in Sea…
  continue reading
 
In this episode of Vital Psychedelic Conversations, David interviews Sara Reed: Vital instructor, lecturer, and lead psychedelic research therapist at Imperial College London; and Alex H. Robinson: Vital student, integration coach and psilocybin facilitator for Heroic Hearts Project, and distinguished Army SOF combat Veteran with a decade of active…
  continue reading
 
In most cases, the immune system detects and destroys cells that could become cancerous every day. For cancer to ravage the body, it needs to evade the immune system by shutting off its response. SIRPant Immunotherapeutics is seeking to address cancer by activating and modifying a patient’s own macrophages to awaken the immune system to cancer. The…
  continue reading
 
In this episode, Joe and REMAP Therapeutics Founder, Court Wing, host Lynn Watkins: medically retired USAF JAG & Ops Resource Mgmt Specialist; and C.J. Spotswood, PMHNP: principle psychiatric clinician at REMAP Therapeutics, and author of The Microdosing Guidebook: A Step-by-Step Manual to Improve Your Physical and Mental Health through Psychedelic…
  continue reading
 
In this episode of Vital Psychedelic Conversations, David interviews Casey Paleos, MD: Vital instructor, researcher, psychiatrist with a private practice offering ketamine infusion therapy and KAP, and co-founder of Nautilus Sanctuary, a non-profit psychedelic research, education, and advocacy organization. Paleos talks about how stress creates tra…
  continue reading
 
As the founder of SynBioBeta, John Cumbers has long evangelized to investors, entrepreneurs, and forward-thinking industrialists about the emergence of the bioeconomy. Cumbers, however, wants to share his sense of wonder about molecular biology with a broader audience through his new venture, Biological Enlightenment Studios. His ambition is for th…
  continue reading
 
In this episode, Kyle interviews Peter A. Levine, Ph.D.: developer of Somatic Experiencing®, educator, and author of several best-selling books on trauma. His most recent book, An Autobiography of Trauma: A Healing Journey, is exactly that: a change from more scholarly writing into an extremely vulnerable telling of his early childhood trauma and h…
  continue reading
 
In this episode of Vital Psychedelic Conversations, Johanna interviews Erika Dyck: author, professor, historian, Vital instructor, and research chair in the History of Health & Social Justice at the University of Saskatchewan. Dyck talks about the book she co-edited: Women and Psychedelics: Uncovering Invisible Voices, which was released in March a…
  continue reading
 
Subodha Kumar, professor of statistics, operations, and data science and the founding director of the Center for Business Analytics and Disruptive Technologies at Temple University’s Fox School of Business, sits down with Amar Drawid to discuss how AI will improve operational efficiency in healthcare, enable mass customization for patients, and fre…
  continue reading
 
Electronic health records are a rich source of real-world data that can provide insights into health and wellness. Neal Meropol, head of research oncology at Flatiron Health, said they not only have value as a research tool for retrospective studies, but can be a treasure trove of information for prospective studies as well. We spoke to Meropol abo…
  continue reading
 
In this episode, Joe interviews Lia Mix, LMFT, CPTR: founder and CEO of Delphi, a consulting firm dedicated to the healthy growth of the psychedelic movement. After many years of working in community mental health and 15 years in the commercial health insurance industry (where she helped to establish coverage for autism), Mix was one of the first g…
  continue reading
 
In this episode of Vital Psychedelic Conversations, David interviews Kaitlin Roberson: Vital graduate and co-founder and CEO of Cacti Therapeutics, a psychedelic biotech company developing novel therapies for chronic pain; and Dr. Michele Cox, DO: current Vital student, veteran, physician, and co-founder of LifeBloom, a brand new company focusing o…
  continue reading
 
Earlier this year, Profluent announced it had edited the human genome with OpenCRISPR-1, the world’s first AI-created and open-source gene editor. Though the open-source aspect helped garner attention for Profluent, it also served as a demonstration of the company’s generative AI platform to create novel CRISPR gene editors. We spoke to Hilary Eato…
  continue reading
 
In this episode, Joe interviews Dr. Amanda Holley: pharmacologist and regulatory consultant in nonclinical drug development, and previously a nonclinical pharmacology/toxicology reviewer at the FDA. With Lykos Therapeutics working towards FDA approval of MDMA-assisted psychotherapy for PTSD, ICER (Institute for Clinical and Economic Review) recentl…
  continue reading
 
In this episode of Vital Psychedelic Conversations, Kyle interviews two Vital graduates: Alice Dommert: certified breathwork facilitator and co-founder of retreat company, The Infinite Center; and Kara Tremain, ACC: somatic practitioner and growth and development coach. A huge part of Vital is the experiential aspect of attending a retreat. Student…
  continue reading
 
Mati Gill, CEO of AION Labs, sits down with Amar Drawid to discuss how the AI venture studio works with its Big Pharma partners to define the biggest drug development hurdles the industry faces; and how it holds challenges to attract academics, entrepreneurs, and life sciences professionals with the best solutions to build new companies.…
  continue reading
 
About 500,000 people suffer from a spinal cord injury each year. Treatments can involve surgical procedures to stabilize the spine and physical rehabilitation, which can have limited benefits. There are currently no FDA-approved therapies that can promote repair and improve function following a spinal cord injury. NervGen Pharma is seeking to chang…
  continue reading
 
In this episode, Joe interviews Charles Stang: Professor of Early Christian Thought and the Director of the Center for the Study of World Religions at Harvard Divinity School. The Center was created to gain a better understanding of world religions by bringing scholars from their respective countries to study and live alongside Divinity School stud…
  continue reading
 
In this episode – the first in the 2024 series of Vital Psychedelic Conversations – David interviews Pierre Bouchard, LPC: Vital instructor and lead trainer for the Congregation for Sacred Practices; and Kara Tremain, ACC: recent Vital graduate-turned-instructor, somatic practitioner, and growth and development coach. In this series, we pair up a V…
  continue reading
 
One of the challenges of treating neurodegenerative diseases is delivering therapies across the blood-brain barrier. Aliada Therapeutics is developing therapies that use its platform technology that enables the delivery of large molecules, like antibodies, across that barrier. Its lead program is in development to treat Alzheimer’s disease. We spok…
  continue reading
 
In this episode, Kyle interviews Alex Belser, Ph.D. and Bill Brennan, Ph.D.: psychologists, psychedelic researchers, authors, and co-creators of the EMBARK model, a framework for psychedelic therapy. When Belser and Brennan worked together at Cybin, they canvassed the field of psychedelic research and saw very little reporting (if any) of the manua…
  continue reading
 
Sherry Goldman's guest is Chris Winans, a strategic communications advisor working mostly with the insurance industry and founder of Chris Winans Consulting. Sherry and Chris discuss Chris' experience in insurance industry crisis communications (including at AIG) and best practices for media relations in a crisis communications effort.…
  continue reading
 
In this episode, special guest host Court Wing interviews Monica Verduzco-Gutierrez, MD: professor and chair of rehabilitation medicine at UT Health San Antonio; Joel Castellanos, MD: co-founder and associate medical director of the Center for Psychedelic Research at UC San Diego; and MaryAnn Welke Lesage: a long COVID survivor who reports experien…
  continue reading
 
Loading …

Quick Reference Guide